Clinical Trial Update: Hepatic Impairment, Cholestatic Liver Disease, & NASH with Advanced Fibrosis & Normal Hepatic Function [Phase 1]

View source ↗

Summary

Phase 1 trial by Zydus Therapeutics evaluating hepatic impairment, cholestatic liver disease, and nonalcoholic steatohepatitis with advanced fibrosis in individ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholestatic Liver Disease
• Hepatic Impairment
• Nonalcoholic Steatohepatitis with Advanced Fibrosis

Snippet

Sponsor: Zydus Therapeutics Inc. | Conditions: Hepatic Impairment | Phase 1 | Status: COMPLETED